Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
journalStr:"WHO International Clinical Trials Registry Platform"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Fibrosis%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
/vufind/Search/Results?lookfor=%22Fibrosis%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
Search /vufind/Search2/Results?lookfor=%22Fibrosis%22&type=Subject&filter%5B%5D=journalStr%3A%22WHO+International+Clinical+Trials+Registry+Platform%22
PubPharm (4.664)
1
A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy : A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
Investigation to Efficacy and Safety of CC-90001 in patients with Idiopathic Pulmonary Fibrosis : A Phase 2, 24-Week Randomized, Double-blind, Placebo-ControlledMulticenter Study, With an 80-Week Active Treatment Extension, toEvaluate the Efficacy and Safety of CC-90001 in Subjects with IdiopathicPulmonary Fibrosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects : A Phase 3b Open-label Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Cystic Fibrosis Subjects
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
A Study Evaluating the Long-term Safety of VX-445 Combination Therapy : A Phase 3, Open-label Study Evaluating the Long-term Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis - A Study Evaluating the Long-term Safety of VX-445 Combination Therapy
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
A Study to Assess the Efficacy and Safety of Study Drug INS1007 Administered Once Daily in Patients with Non-Cystic Fibrosis Bronchiectasis. : A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multi-Center Study to Assess the Efficacy, Safety and Tolerability, and Pharmacokinetics of INS1007 Administered Once Daily for 24 Weeks in Subjects with Non-Cystic Fibrosis Bronchiectasis - The Willow Study.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
A Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy : A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous or Heterozygous for the F508del Mutation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
A Study Evaluating Safety and Efficacy of VX-659 Combination Therapy in Subjects With Cystic Fibrosis : A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-659 Combination Therapy in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del Mutation (F/F)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
A pilot study evaluating the safety of intravenously administered human amnion epithelial cells for the treatment of hepatic fibrosis : A pilot study evaluating the safety of intravenously administered human amnion epithelial cells for the treatment of hepatic fibrosis
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
A study to assess the efficacy and safety of a combination of two experimental drugs in people with cystic fibrosis (a rare hereditary lung disease) : A Phase 3, Open-label, Rollover Study to Evaluate the Safety and Efficacy of Long term Treatment With VX 661 in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous or Heterozygous for the F508del CFTR Mutation
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
A Study to Evaluate the Relative Bioavailability of Tezacaftor/Ivacaftor Granules : A Phase 1, Open-label, Randomized, Crossover Study to Evaluate the Relative Bioavailability of a Granule Formulation of Tezacaftor and Ivacaftor Compared to a Fixed-dose Combination Tablet in Healthy Adult Subjects
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[467]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Zeitschrift: WHO International Clinical Trials Registry Platform
Medienart
4.664
Aufsätze
4.664
E-Artikel
4.664
E-Ressourcen
Zeitschriftentitel
WHO International Clinical Trials Registry Plat...
Thema
4.664
610
4.154
Study Type: Interventional
2.544
Recruitment Status: Not yet recruiting
1.146
Phase: Phase 3
876
Phase: Phase 2
588
Recruitment Status: Recruiting
578
Recruitment Status: Authorised-recruitment may ...
564
Recruitment Status: Completed
410
Study Type: Observational
228
Phase: Phase 4
226
Medical Condition: Cystic Fibrosis MedDRA versi...
132
Recruitment Status: Complete: follow-up complete
116
Phase: Phase 1
72
Medical Condition: Cystic fibrosis MedDRA versi...
66
Medical Condition: Health Condition 1: K135- Or...
64
Medical Condition: Idiopathic pulmonary fibrosis
60
Medical Condition: Idiopathic pulmonary fibrosi...
56
Medical Condition: idiopathic pulmonary fibrosis
46
Study Type: Diagnostic test
44
Medical Condition: Health Condition 1: K74- Fib...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
2.716
2020-
1.948
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
4.556
Englisch
52
Unbestimmt
26
Spanisch
10
Niederländisch
10
Französisch
4
Deutsch
4
Ungarisch
2
Italienisch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...